Polskie Radio covers the approval of Novo Nordisk's Wegovy in China. The link carries no further detail on timing or terms.
Recap by typeshit. Full story at www.polskieradio.pl.
12:50
Alex Wallace, who bills himself as a peptide expert, gives his response to what Dr. Mike has said about peptides. Details beyond the title are thin.
A search result from Polskie Radio on the approval status of tirzepatide for weight loss, with no further detail provided beyond the question itself.
A Facebook post credits Novo Nordisk's GLP-1 drugs with strong results in obesity and type 2 diabetes, plus lower risk of other conditions.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
Dr. Zheng says the drugs have been associated with NAION, an eye condition that can cause permanent vision loss, and points to patients with risk factors.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
Loading…